Parvin Asset Management’s Phibro Animal Health PAHC Stock Holding History

Parvin Asset Management’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$372K	Sell	11,835 -15	-0.1%	-$633	0.29%	92
2026 Q1	$655K	Buy	11,850 +150	+1%	+$7.14K	0.47%	70
2025 Q4	$437K	Sell	11,700 -250	-2%	-$10.2K	0.35%	82
2025 Q3	$483K	Sell	11,950 -25	-0.2%	-$826	0.42%	73
2025 Q2	$306K	Hold	11,975	–	–	0.31%	87
2025 Q1	$256K	Sell	11,975 -1,475	-11%	-$33K	0.28%	92
2024 Q4	$282K	Buy	+13,450	New	+$311K	0.3%	88

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Parvin Asset Management's PAHC Position: Q2 2026 in Review

Parvin Asset Management reduced its Phibro Animal Health (PAHC) stake by 0.13% in Q2 2026, selling an estimated $633 and leaving 11,835 shares worth $372K. The position accounts for 0.29% of the portfolio, ranked #92.

Parvin Asset Management first reported a position in PAHC in Q4 2024 and has held it in 7 quarters since. The position peaked at $655K in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

Parvin Asset Management held 11,835 shares of Phibro Animal Health worth $372K as of Q2 2026.
Parvin Asset Management sold 15 Phibro Animal Health shares in Q2 2026, an estimated $633.
Phibro Animal Health made up 0.29% of Parvin Asset Management's portfolio in Q2 2026, its #92 holding.
Parvin Asset Management first reported a position in Phibro Animal Health in Q4 2024 and has held it in 7 quarters since.
Parvin Asset Management's Phibro Animal Health position peaked at $655K in Q1 2026.
208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Parvin Asset Management's 13F filing for Q2 2026, filed 17 Aug 2026.